Published in Calcif Tissue Int on March 24, 2010
Building strong bones: molecular regulation of the osteoblast lineage. Nat Rev Mol Cell Biol (2011) 3.51
Update on Wnt signaling in bone cell biology and bone disease. Gene (2011) 2.03
Development of the endochondral skeleton. Cold Spring Harb Perspect Biol (2013) 1.89
Lrp5 and Lrp6 redundantly control skeletal development in the mouse embryo. Dev Biol (2011) 1.59
Life without peripheral serotonin: insights from tryptophan hydroxylase 1 knockout mice reveal the existence of paracrine/autocrine serotonergic networks. ACS Chem Neurosci (2012) 1.23
Lrp5 and Lrp6 exert overlapping functions in osteoblasts during postnatal bone acquisition. PLoS One (2013) 1.08
The two faces of serotonin in bone biology. J Cell Biol (2010) 1.05
SOST and DKK: Antagonists of LRP Family Signaling as Targets for Treating Bone Disease. J Osteoporos (2010) 0.91
Serotonin: a novel bone mass controller may have implications for alveolar bone. J Negat Results Biomed (2013) 0.84
Serum serotonin levels and bone in rheumatoid arthritis patients. Rheumatol Int (2017) 0.75
Endocrine regulation of energy metabolism by the skeleton. Cell (2007) 10.41
Leptin regulates bone formation via the sympathetic nervous system. Cell (2002) 5.95
Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum. Cell (2008) 5.93
Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism. Cell (2010) 5.08
Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc Natl Acad Sci U S A (2008) 4.77
Endocrine regulation of male fertility by the skeleton. Cell (2011) 3.20
Pharmacological inhibition of gut-derived serotonin synthesis is a potential bone anabolic treatment for osteoporosis. Nat Med (2010) 2.32
Bone mass and hormone analysis in patients with spinal cord injury: evidence for a gonadal axis disruption. J Clin Endocrinol Metab (2014) 2.04
Efficacy of serotonin inhibition in mouse models of bone loss. J Bone Miner Res (2011) 1.84
Intermittent injections of osteocalcin improve glucose metabolism and prevent type 2 diabetes in mice. Bone (2011) 1.75
Osteocalcin promotes β-cell proliferation during development and adulthood through Gprc6a. Diabetes (2013) 1.68
Fibrillin-1 and -2 differentially modulate endogenous TGF-β and BMP bioavailability during bone formation. J Cell Biol (2010) 1.49
High-intensity aquatic exercises (HydrOS) improve physical function and reduce falls among postmenopausal women. Menopause (2013) 1.45
[Parathyroid carcinoma]. Arq Bras Endocrinol Metabol (2006) 1.39
A novel role for GADD45beta as a mediator of MMP-13 gene expression during chondrocyte terminal differentiation. J Biol Chem (2005) 1.30
An ELISA-based method to quantify osteocalcin carboxylation in mice. Biochem Biophys Res Commun (2010) 1.29
Parathyroid hormone bone anabolic action requires Cbfa1/Runx2-dependent signaling. Mol Endocrinol (2002) 1.26
Treatment of vitamin D deficiency increases lower limb muscle strength in institutionalized older people independently of regular physical activity: a randomized double-blind controlled trial. Ann Nutr Metab (2009) 1.19
Hypoparathyroidism and pseudohypoparathyroidism. Arq Bras Endocrinol Metabol (2006) 1.13
Dickkopf-like1 regulates postpubertal spermatocyte apoptosis and testosterone production. Endocrinology (2008) 1.09
Association between lean mass and handgrip strength with bone mineral density in physically active postmenopausal women. J Clin Densitom (2010) 1.06
Influence of ultraviolet radiation on the production of 25 hydroxyvitamin D in the elderly population in the city of São Paulo (23 degrees 34'S), Brazil. Osteoporos Int (2005) 1.05
Relationship between bone mineral density, leptin and insulin concentration in Brazilian obese adolescents. J Bone Miner Metab (2009) 1.01
Characterization of an osteoblast-specific enhancer element in the CBFA1 gene. J Biol Chem (2002) 0.98
Circulating sclerostin in disorders of parathyroid gland function. J Clin Endocrinol Metab (2011) 0.96
Lrp5 and bone formation : A serotonin-dependent pathway. Ann N Y Acad Sci (2010) 0.93
Teriparatide increases bone mineral density in a man with osteoporosis pseudoglioma. J Bone Miner Res (2011) 0.92
Evidence-based non-skeletal actions of vitamin D. Arq Bras Endocrinol Metabol (2010) 0.91
[Prevalence of vitamin D deficiency, insufficiency and secondary hyperparathyroidism in the elderly inpatients and living in the community of the city of São Paulo, Brazil]. Arq Bras Endocrinol Metabol (2007) 0.91
Safety and efficacy of a 1-year treatment with zoledronic acid compared with pamidronate in children with osteogenesis imperfecta. J Pediatr Endocrinol Metab (2012) 0.90
[Evidences of physical agents action on bone metabolism and their potential clinical use]. Arq Bras Endocrinol Metabol (2006) 0.90
Influence of visceral and subcutaneous fat in bone mineral density of obese adolescents. Arq Bras Endocrinol Metabol (2012) 0.88
The role of pro/anti-inflammatory adipokines on bone metabolism in NAFLD obese adolescents: effects of long-term interdisciplinary therapy. Endocrine (2012) 0.88
[High morbid-mortability and reduced level of osteoporosis diagnosis among elderly people who had hip fractures in São Paulo City]. Arq Bras Endocrinol Metabol (2008) 0.87
Physical approach for prevention and treatment of osteoporosis. Arq Bras Endocrinol Metabol (2010) 0.87
[Usefulness of intraoperative PTH measurement in primary and secondary hyperparathyroidism: experience with 109 patients]. Arq Bras Endocrinol Metabol (2006) 0.87
Autoimmune polyendocrine syndrome type 1: case report and review of literature. Arq Bras Endocrinol Metabol (2012) 0.86
Three years follow-up of pamidronate therapy in two brothers with osteoporosis-pseudoglioma syndrome (OPPG) carrying an LRP5 mutation. J Pediatr Endocrinol Metab (2008) 0.86
Mechanical vibration preserves bone structure in rats treated with glucocorticoids. Bone (2010) 0.84
Co-dependence of bone and energy metabolisms. Arch Biochem Biophys (2010) 0.83
Do patients with osteogenesis imperfecta need individualized nutritional support? Nutrition (2011) 0.83
Diagnosis and management of primary hyperparathyroidism--a scientific statement from the Department of Bone Metabolism, the Brazilian Society for Endocrinology and Metabolism. Arq Bras Endocrinol Metabol (2013) 0.83
Effects of creatine supplementation on body composition and renal function in rats. Med Sci Sports Exerc (2005) 0.80
Increases in summer serum 25-hydroxyvitamin D (25OHD) concentrations in elderly subjects in São Paulo, Brazil vary with age, gender and ethnicity. BMC Endocr Disord (2010) 0.80
Factors affecting vitamin D status in different populations in the city of São Paulo, Brazil: the São PAulo vitamin D Evaluation Study (SPADES). BMC Endocr Disord (2013) 0.79
[Changes in bone metabolism markers in women after Roux-en-Y gastric bypass]. Arq Bras Endocrinol Metabol (2012) 0.78
Bisphosphonates in the treatment of metabolic bone diseases. Arq Bras Endocrinol Metabol (2010) 0.78
Parathyroid carcinoma and hungry bone syndrome. Arq Bras Endocrinol Metabol (2013) 0.77
Bone mineral density in spinal cord injury: an evaluation of the distal femur. J Osteoporos (2012) 0.76
Bone mineral density and osteoporosis among a predominantly Caucasian elderly population in the city of São Paulo, Brazil. Osteoporos Int (2005) 0.76
High degree of discordance between three-dimensional and two-dimensional lumbar spine bone mineral density in Turner's syndrome. J Clin Densitom (2005) 0.75
Response to the letter by Francavilla F. and Barbonetti A. J Clin Endocrinol Metab (2015) 0.75
The effects of discontinuing long term alendronate therapy in a clinical practice setting. Arq Bras Endocrinol Metabol (2011) 0.75
[Why evaluate bone mineral density in children and adolescents?]. J Pediatr (Rio J) (2004) 0.75
[Control of body mass by leptin occurs through the sympathetic nervous system]. Med Sci (Paris) (2003) 0.75
Intraoperative PTH cutoff definition to predict successful parathyroidectomy in secondary and tertiary hyperparathyroidism. Braz J Otorhinolaryngol (2013) 0.75
[FRAX: building an idea to Brazil]. Arq Bras Endocrinol Metabol (2009) 0.75
[Diabetes mellitus, thiazolidinediones and fractures: an unfinished story]. Arq Bras Endocrinol Metabol (2010) 0.75
Molecular signaling: breakout session summary. Ann N Y Acad Sci (2002) 0.75
Whole-body vibration improves neuromuscular parameters and functional capacity in osteopenic postmenopausal women. Menopause (2016) 0.75
Osteogenesis imperfecta: diagnosis and treatment. Curr Opin Endocrinol Diabetes Obes (2017) 0.75
Hormones and bone. Arq Bras Endocrinol Metabol (2010) 0.75
[The environmental endocrine disruptors must receive the attention of Brazilian endocrinologists]. Arq Bras Endocrinol Metabol (2011) 0.75
[Discrepancy between IGF-1 and GH during 75 g oral glucose tolerance test measures to acromegaly screening in a patient with macroprolactinoma--case report and literature review]. Arq Bras Endocrinol Metabol (2007) 0.75
Vitamin D supplementation and strontium ranelate absorption in postmenopausal women with low bone mass. Eur J Endocrinol (2014) 0.75
[The prevention of osteoporosis taken seriously: a national need]. Arq Bras Endocrinol Metabol (2008) 0.75
25-Hydroxyvitamin D level does not reflect intestinal calcium absorption: an assay using strontium as a surrogate marker. J Bone Miner Metab (2014) 0.75